This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Good Answers Spawn Pressing Questions

Bernadine Healy, MD

JAMA. 1995;273(3):240-241.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Estrogen is good for a woman's heart. While generally accepted when the estrogen is produced naturally, this theory has been a matter of great controversy when the estrogen is administered "artificially" in hormone replacement therapy (HRT) for women during and after menopause. After a half century of conflicting data, we can affirm with growing confidence that, at the very least, estrogen reduces key cardiovascular risk factors in women at a time when they become especially vulnerable to heart disease, namely, after 50 years of age.

See also p 199.

In this issue of THE JOURNAL, the Postmenopausal Estrogen/Progestin Interventions (PEPI) investigators report on one aspect of the many findings that we can expect to learn over the next few years from their important National Institutes of Health (NIH)-supported multicenter efforts.¹ Their report focuses on the effect of HRT, given in four different formulations, compared with short-term use of placebo . . . [Full Text PDF of this Article]

Author Affiliations
From the Page Center for Health and Science Policy Studies, the Cleveland Clinic Foundation, Cleveland, Ohio.

Footnotes
Reprint requests to the Cleveland Clinic Foundation, One Clinic Center, 9500 Euclid Ave, Cleveland, OH 44195-5108 (Dr Healy).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?